Skip to main content
SpringerLink
Log in

QOL impact of ‘Neoral’ use in patients with psoriasis

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL impact of ‘Neoral’ use in patients with psoriasis. Pharmacoecon. Outcomes News 120, 10–11 (1997). https://doi.org/10.1007/BF03271790

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03271790

Keywords

Search

Navigation